Study on Cabozantinib and Dostarlimab for Recurrent Gynecologic Carcinosarcoma | Clinical Trial

Study on Cabozantinib and Dostarlimab for Recurrent Gynecologic Carcinosarcoma | Clinical Trial | Right2Hope